Russell Investments Group
NEXI

Russell Investments Group’s NexImmune, Inc. Common Stock NEXI Stock Holding History

Russell Investments Group’s Portfolio NEXI Stock Details NEXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-97
Closed -$39K – 3255
2021
Q2 		$39K Buy
+97
New +$44.7K ﹤0.01% 3150

Other funds holding NEXI

ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AO
Allen Operations New York $670M AUM 26.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

Russell Investments Group's NEXI Position: Q3 2021 in Review

Russell Investments Group sold out of NexImmune, Inc. Common Stock (NEXI) in Q3 2021, closing a stake of 97 shares — an estimated $39K sold.

Russell Investments Group first reported a position in NEXI in Q2 2021 and held it in 1 quarter. The position peaked at $39K in Q2 2021. 47 funds tracked by Wall St. Rank hold NEXI as of Q3 2021.

  • Russell Investments Group reported no remaining NexImmune, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Russell Investments Group sold 97 NexImmune, Inc. Common Stock shares in Q3 2021, an estimated $39K.
  • Russell Investments Group first reported a position in NexImmune, Inc. Common Stock in Q2 2021 and held it in 1 quarter.
  • Russell Investments Group's NexImmune, Inc. Common Stock position peaked at $39K in Q2 2021.
  • 47 funds tracked by Wall St. Rank held NexImmune, Inc. Common Stock as of Q3 2021.

Based on Russell Investments Group's 13F filing for Q3 2021, filed 8 Nov 2021.